Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
SMHGF:OTCMKTS
Simcere Pharmaceutical Group Ltd
$1.49
0.00%
(0.00) 1D
Mar 9, 9:30:04 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMHGF...
Mkt. cap
31.41B
Avg. vol.
0.00
Volume
0.00
52-wk high
$1.96
52-wk low
$1.96
Beta
-0.36
Shares outstanding
2.60B
No. of employees
7K
News stories
From sources across the web
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees7.04K
Founded1995
HeadquartersNanjing, Jiangsu, China
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.79B
1.79B
2.07B
2.07B
Cost of goods sold
345.53M
345.53M
365.25M
365.25M
Cost of revenue
345.53M
345.53M
365.25M
365.25M
Research and development expenses
316.21M
316.21M
465.30M
465.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
807.37M
807.37M
949.52M
949.52M
Operating expense
1.09B
1.09B
1.36B
1.36B
Total operating expenses
1.44B
1.44B
1.72B
1.72B
Operating income
357.23M
357.23M
351.33M
351.33M
Other non operating income
-
-
-
-
EBT including unusual items
331.24M
331.24M
425.92M
425.92M
EBT excluding unusual items
350.09M
350.09M
348.89M
348.89M
Income tax expense
29.44M
29.44M
55.72M
55.72M
Effective tax rate
8.89%
8.89%
13.08%
13.08%
Other operating expenses
-34.30M
-34.30M
-56.27M
-56.27M
Net income
301.80M
301.80M
370.20M
370.20M
Net profit margin
16.84%
16.84%
17.86%
17.86%
Earnings per share
-
-
-
-
Interest and investment income
13.27M
13.27M
14.60M
14.60M
Interest expense
-24.27M
-24.27M
-23.63M
-23.63M
Net interest expenses
-10.99M
-10.99M
-9.03M
-9.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
409.84M
409.84M
403.94M
407.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more